Results 51 to 60 of about 131,232 (324)

Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundTimely reperfusion after ST‐elevation myocardial infarction (STEMI) improves survival. Guidelines recommend primary percutaneous coronary intervention (PPCI) within 90 minutes of arrival at a PCI‐capable hospital.
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid   +15 more
doaj   +1 more source

Thrombin activatable fibrinolysis inhibitor como preditor de sangramento no transplante hepático: estudo piloto observacional

Revista Brasileira de Terapia Intensiva
RESUMO Objetivo: Correlacionar os níveis de thrombin activatable fibrinolysis inhibitor no pós-operatório imediato e com 24 horas de pós-operatório com o volume de sangramento tansoperatório.
Wagner Luis Nedel, Edison Moraes Rodrigues Filho, Alessandro Comarú Pasqualotto   +2 more
doaj   +1 more source

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation

Cardiovascular Diabetology, 2021
A prothrombotic state is a typical feature of type 2 diabetes mellitus (T2DM). Apart from increased platelet reactivity, endothelial dysfunction, hyperfibrinogenemia, and hypofibrinolysis are observed in T2DM.
Agata Hanna Bryk-Wiązania, Anetta Undas
doaj   +1 more source

Measuring fibrinolysis: from research to routine diagnostic assays

Journal of Thrombosis and Haemostasis, 2018
Development and standardization of fibrinolysis methods have progressed more slowly than coagulation testing and routine high‐throughput screening tests for fibrinolysis are still lacking. In laboratory research, a variety of approaches are available and
C. Longstaff
semanticscholar   +1 more source

Local fibrinolysis in surgical treatment of traumatic intracranial hemorrhage

Ukrainian Neurosurgical Journal, 2008
This review is devoted to the problem of new miniinvasive method of local fibrinolysis application in surgical treatment of traumatic intracranial hemorrhage.
K. I. Gorbatyuk, A. S. Gotin
doaj   +1 more source

FIBRINOLYSIS: MODERN VIEW, PATHOLOGY, DIAGNOSTICS

Байкальский медицинский журнал
Relevance. Fibrinolysis is an important and integral part of the hemostasis system. Acting in parallel and together, the blood coagulation and fibrinolysis systems protect the body from excessive thrombus formation and vascular occlusion, on the one hand,
Lyudmila O. Gutsol, Irina E. Egorova, Igor Zh. Seminsky, Evgenia V. Guzovskaiia, Svetlana N. Serebrennikova, Lyudmila A. Dmitrieva   +5 more
doaj   +1 more source

Adrenaline May Contribute to Prothrombotic Condition via Augmentation of Platelet Procoagulant Response, Enhancement of Fibrin Formation, and Attenuation of Fibrinolysis

Frontiers in Physiology, 2021
Background: Adrenaline is believed to play a role in thrombosis and hemostasis. The complex effect of its clinically relevant concentrations on thrombus formation, coagulation and fibrinolysis in human blood has never been specifically studied.Methods ...
Agata Golaszewska, Tomasz Misztal, Natalia Marcinczyk, Ewa Chabielska, Tomasz Rusak   +4 more
doaj   +1 more source

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Journal of Clinical Medicine, 2019
A disruption of immune checkpoints leads to imbalances in immune homeostasis, resulting in immune-related adverse events. Recent case studies have suggested the association between immune checkpoint inhibitors (ICIs) and the disorders of the coagulation ...
R. Sato, K. Imamura, S. Sakata, T. Ikeda, Y. Horio, S. Iyama, K. Akaike, S. Hamada, T. Jodai, K. Nakashima, Shiho Ishizuka, Nahoko Sato, K. Saruwatari, S. Saeki, Y. Tomita, T. Sakagami   +15 more
semanticscholar   +1 more source

Studies on an antifibrinolytic agent trans-AMCHA [PDF]

, 1968
Lysis of fibrin was first recognized by MORGAGNI in 1769, observing a liquid blood in a patient of acute death, and the phenomenon was named as fibrinolysis by DASTRE in 1893.
Fujiyama, Noboru, Morimoto, Setsuo, Ohmoto, Takechiyo, Shigemoto, Hirosada, Shimizu, Hiroshi, Sunada, Terutake   +5 more
core   +1 more source

Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays

Journal of Trauma and Acute Care Surgery, 2019
INTRODUCTION Fibrinolysis was initially defined using rapid thrombelastography (rTEG). The cutoffs for the pathologic extremes of the fibrinolytic system, hyperfibrinolysis and shutdown, were both defined based on association with mortality.
Gregory R Stettler, E. Moore, H. Moore, Geoffrey R. Nunns, C. Silliman, A. Banerjee, A. Sauaia   +6 more
semanticscholar   +1 more source